Table 3.

Overall Cohort Outcomes

Variable	Overall (n=220)	Open (n=69)	Minimum (n=151)	P value
Hospital stay (days)	2.9 ± 3.4	4.3 ± 4.0	2.0 ± 2.6	<0.001
Operative time (min)	187.2 ± 91.5	223.5 ± 100.4	170.7 ± 82.0	<0.001
ICU stay (days)	0.5 ± 2.0	1.2 ± 2.8	0.2 ± 1.3	<0.001
Post-op complication
Re-operation	5 (2%)	3 (4%)	2 (1%)	0.16
Arrhythmia	12 (5%)	7 (10%)	5 (3%)	0.03
Surgical site infection	3 (1%)	2 (3%)	1 (1%)	0.18
Neurological deficit	0	0	0	1.00
Acute kidney injury	1 (0%)	1 (1%)	0	0.13
30 Day readmission	13 (6%)	5 (8%)	8 (5%)	0.57
Total cost	171,201 ± 14,987	22,847 ± 20,061	14,504 ± 10,845	<0.001
Non Thymoma	179 (81%)	51 (74%)	128 (85%)	0.08
Thymoma	41 (19%)	18 (26%)	23 (15%)
WHO classification
A	4 (10%)	0	4 (17%)	0.18
AB	11 (27%)	6 (33%)	5 (22%)	0.63
B1	10 (24%)	2 (11%)	8 (35%)	0.16
B2	6 (15%)	2 (11%)	4 (17%)	0.90
B3	8 (20%)	6 (33%)	2 (9%)	0.11
C	2 (5%)	2 (11%)	0	0.40
R0 resection	41 (100%)	18 (100%)	23 (100%)	1.00

^*Non Thymoma pathologies included: Thymic cyst, normal thymus, thymic hyperplasia